Evotec SE header image

Evotec SE

EVT

Equity

ISIN DE0005664809 / Valor 505433

Xetra (2025-04-04)

EUR 5.51-6.53%

Evotec SE
UMushroom community rating:

4.29 7 votes No rating yet

NegativeNeutralPositive

About company

Evotec SE is a global platform company focused on discovering and developing highly effective therapeutics in various therapeutic areas such as neurology, oncology, metabolic, and infectious diseases. The company leverages its data-driven multimodality platform and innovative technologies to create a world-leading pipeline of proprietary and co-owned R&D projects. With strategic partnerships with top pharmaceutical companies, biotechnology firms, academic institutions, and other healthcare stakeholders, Evotec aims to make its pharmaceutical products globally available to patients in need. Operating globally with over 5,000 employees across 17 sites in six countries, Evotec is committed to accelerating innovations and developing new drug discovery projects through collaborations within EVT Innovate.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-60.9%1Y

-80.5%3Y

-73.7%5Y

Performance

87.1%1Y

64.3%3Y

56.1%5Y

Volatility

1576 M

Market cap (USD)

1,138,742

Daily traded volume (Shares)

8.73 / 8.45

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.29

7 votes

Performance:

4.29

Innovation:

4.29

Society:

4.00

Nature:

3.86

Meret Jaggi

Switzerland, 30 May 2022

Oliver Moon

Switzerland, 30 May 2022

German biotech/ pharma company. Decent upside potential. Analyst buy. Good performance history. Seems good to me.

Atanas WI Atanasov

Switzerland, 30 May 2022

EQUITIES OF THE SAME SECTOR

Orion Oyj

Orion Oyj Valor: 2553367

Annual Return

-50%0%+50%

Risk level

110

-5.19%EUR 52.56

Dermapharm Holding SE

Dermapharm Holding SE Valor: 40166352

Annual Return

-50%0%+50%

Risk level

110

-2.60%EUR 35.55

Bausch Health Companies Inc

Bausch Health Companies Inc Valor: 42260834

Annual Return

-50%0%+50%

Risk level

110

-6.30%USD 5.33

Cooper Companies Inc

Cooper Companies Inc Valor: 132951296

Annual Return

-50%0%+50%

Risk level

110

-5.63%USD 73.77

Xlife Sciences Ltd.

Xlife Sciences Ltd. Valor: 46192960

Annual Return

-50%0%+50%

Risk level

110

-7.89%CHF 21.00

Straumann Holding Ltd

Straumann Holding Ltd Valor: 117544866

Annual Return

-50%0%+50%

Risk level

110

-5.22%CHF 93.98

Lifco Ab

Lifco Ab Valor: 111355378

Annual Return

-50%0%+50%

Risk level

110

-4.17%SEK 335.80

PharmaSGP Holding SE

PharmaSGP Holding SE Valor: 55294050

Annual Return

-50%0%+50%

Risk level

110

-1.63%EUR 24.20

MannKind Corp

MannKind Corp Valor: 35935511

Annual Return

-50%0%+50%

Risk level

110

-2.87%USD 4.74

The Platform Group AG

The Platform Group AG Valor: 57796644

Annual Return

-50%0%+50%

Risk level

110

-2.64%EUR 8.86

SIX

FactSet

Clearbit

Logos provided by Clearbit